or Try an Advanced Search...

    Technical Analysis for IGC - India Globalization Capital Inc.

    Grade Last Price % Change Price Change
    D 0.44 1.24% 0.01
    IGC closed up 1.24 percent on Monday, July 1, 2024, on 17 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Flat
    Historical IGC trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Up 3 Days in a Row Strength 0.00%
    Wide Bands Range Expansion 1.24%
    Wide Bands Range Expansion 3.34%
    Wide Bands Range Expansion 4.32%
    Down 3 Days in a Row Weakness 4.32%
    Gapped Down Weakness 4.32%
    Fell Below 20 DMA Bearish 1.81%
    Wide Bands Range Expansion 1.81%
    Older End-of-Day Signals for IGC ...

       Recent Intraday Alerts

    Alert Time
    Up 1% about 4 hours ago
    Possible NR7 about 6 hours ago
    Down 3% about 10 hours ago
    Down 2 % about 10 hours ago
    Down 1% about 10 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    IGC Chart by TradingView
    Basic chart:

    Profile

    India Globalization Capital Inc is engaged in the development of cannabis-based combination therapies to treat Alzheimer's, pain, nausea, eating disorders, several endpoints of Parkinson's, and epilepsy in humans, dogs, and cats.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Medicine Clinical Medicine Pain Alzheimer's Disease Cannabis Parkinson's Disease Disorders Dog Medicinal Plants Epilepsy Psychiatric Diagnosis Cannabis Smoking Herbalism Medical Cannabis Nausea

    Is IGC a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 25 IGC Pharma's TGR-63 Preclinical Results Show Substantial Reduction in Amyloid Plaque, a Key Hallmark of Alzheimer's Disease
    Jun 25 IGC Pharma GAAP EPS of -$0.22 in-line, revenue of $1.35M beats by $0.11M
    Jun 24 IGC Reports Financial Results for Fiscal Year Ended March 31, 2024
    Jun 18 IGC Pharma to Participate in Fireside Chat with Ascendiant Capital Markets
    Jun 10 IGC Pharma Publishes Study in European Society of Medicine Investigating the Impact of CYP2C9 Genetic Polymorphism on Pharmacokinetics of Delta 9 Tetrahydrocannabinol
    May 28 IGC Pharma Announces Patient Enrollment at Neurostudies in Phase 2 Trial Investigating IGC-AD1
    May 21 IGC Pharma to Attend BIO International Convention 2024
    Apr 16 IGC-AD1’s Interim Phase 2 Data Show a Reduction in Alzheimer’s Agitation at Week Two
    Apr 9 IGC Pharma Adds Advisor in Artificial Intelligence
    Mar 26 IGC Pharma Announces $3 Million Unregistered Private Placement of its Common Stock
    See more IGC news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 0.9099
    52 Week Low 0.2501
    Average Volume 391,060
    200-Day Moving Average 0.37
    50-Day Moving Average 0.48
    20-Day Moving Average 0.44
    10-Day Moving Average 0.44
    Average True Range 0.05
    RSI (14) 47.37
    ADX 24.67
    +DI 23.98
    -DI 13.26
    Chandelier Exit (Long, 3 ATRs) 0.41
    Chandelier Exit (Short, 3 ATRs) 0.53
    Upper Bollinger Bands 0.51
    Lower Bollinger Band 0.38
    Percent B (%b) 0.47
    BandWidth 30.91
    MACD Line -0.01
    MACD Signal Line -0.02
    MACD Histogram 0.0011
    Fundamentals Value
    Market Cap 27.99 Million
    Num Shares 63.7 Million
    EPS -0.20
    Price-to-Earnings (P/E) Ratio -2.20
    Price-to-Sales 14.24
    Price-to-Book 1.38
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.47
    Resistance 3 (R3) 0.47 0.46 0.47
    Resistance 2 (R2) 0.46 0.45 0.46 0.47
    Resistance 1 (R1) 0.45 0.44 0.45 0.45 0.46
    Pivot Point 0.43 0.43 0.43 0.43 0.43
    Support 1 (S1) 0.42 0.42 0.43 0.43 0.41
    Support 2 (S2) 0.41 0.42 0.41 0.41
    Support 3 (S3) 0.40 0.41 0.41
    Support 4 (S4) 0.40